CATALYST FINANCIAL PARTNERS LLC
Position in RVMD — Revolution Medicines, Inc.
CIK 1927537
BOSTON, MA
Position in RVMD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$510,338
+$284,871 QoQ
Shares Held
2,725
-43.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#433
of 687 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CATALYST FINANCIAL PARTNERS LLC holds $1,897,610 across 5 Biotechnology names. RVMD ranks #2 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,320 | $655,683 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
2,725 | $510,338 | |
| 3 | DMAC |
DiaMedica Therapeutics Inc.
|
38,457 | $270,737 | |
| 4 | ABOS |
Acumen Pharmaceuticals, Inc.
|
89,699 | $239,496 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
355 | $221,356 |
All Filings in RVMD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $510,338 | 2,725 | Shares | Sole | 2026-07-30 | |
| 2025-09-30 | $225,467 | 4,828 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||